SEC Form 4 · accession 0001225208-15-012203

Edwards Lifesciences Corp · EW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).

Reporting owner

Officer — Chairman & CEO · Director

Period of report

May 13, 2015

Accepted (ET)

May 15, 2015 · 6:25 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001099800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	May 13, 2015	M	7,426	$0.00	A	271,276	D
Common Stock^F3	holding	—	—		—	61,966	I	401(k)
Common Stock	holding	—	—		—	70,283	I	By Living Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Performance Rights^F1	—	May 13, 2015	D	966	D	—	Mar 31, 2015	Common Stock	966	15,134	D
Performance Rights^F1	—	May 13, 2015	M	7,426	D	—	Mar 31, 2015	Common Stock	7,426	7,708	D
Performance Rights^F1,F2	—	May 13, 2015	F	7,708	D	—	Mar 31, 2015	Common Stock	7,708	0	D

F1On May 9, 2012, the reporting person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 13, 2015, 94% of the target shares vested and were issued and the balance of the award terminated.
F2This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
F3Shares represented on the most recent statement of the 401(k) Plan Administrator where a unitized accounting procedure is utilized to convert the equities to share equivalents.